Defeitos ósseos de grandes dimensões, congênitos ou causados por doenças, traumas ou cirurgias, não se regeneram espontaneamente e são, no geral, um desafio para médicos e dentistas. O presente trabalho apresenta uma revisão crítica sobre estratégias para substituir tecido ósseo ou estimular a osteogênese reparacional. São apresentados conceitos relevantes relativos aos métodos tradicionais de enxertos/implantes ósseos e uso de biomateriais até a aplicação local de fatores de crescimento e a terapia gênica, incluindo comentários críticos sobre eficácia, segurança, dificuldades, vantagens e desvantagens de cada método. Os resultados mais previsíveis ainda são obtidos com enxertos ósseos autógenos, apesar das incoveniências de morbidade e disponibilidade limitada de material. Resultados satisfatórios têm sido relatados com o uso de proteínas ósseas morfogenéticas humanas recombinantes (rhBMPs)-2 e -7, que se distinguem pela capacidade de osteoindução, apesar da necessidade do uso combinado com um carreador biodegradável que permita sua liberação em um ritmo compatível com o da neoformação óssea. Outros fatores de crescimento ósseo estão presentemente em fase pré-clinica de avaliação e sua eficácia também depende de uma estratégia adequada de liberação, além da definição de parâmetros como “qual fator”, “em que dose” e “quando”. Ainda estão sendo estabelecidos os parâmetros de eficiência e segurança para aplicação da terapia gênica em defeitos ósseos. Concluindo, diante da grande variedade de fatores de crescimento envolvidos na complexa cascata do reparo ósseo e das interações que eles estabelecem, definir a melhor estratégia para estimular a formação óssea em situações específicas das práticas médica e odontológica permanece um desafio para cientistas e clínicos.

Large bone defects, congenital or caused by diseases, trauma or surgery, do not heal spontaneously and are usually a clinical challenge in the orthopedic and dental practices. A critical review concerning strategies to substitute lost bone or stimulate osteogenesis was undertaken. Pivotal concepts ranging from traditional bone grafting and use of biomaterials to local application of growth factors and gene therapy were addressed, including critical comments on the efficacy and safety, difficulties, advantages and disadvantages of each method. The most predictable results are still obtained with autogenous bone graft, despite the inconveniences of morbidity and limited availability of graft material. Satisfactory results have been reported for recombinant bone morphogenetic proteins (rhBMPs)-2 and -7, which distinguish for their osteoinductive property, the difficulty being the need for a degradable carrier that allows its continuous release in a rate compatible to that of new bone formation. Other bone growth factors are currently under evaluation in preclinical models of bone defects; however their efficacy is also dependent on the competence of a delivery strategy and on an appropriate delineation of “which one”, “which dose” and “when”. Parameters of efficiency and safety for gene therapy are still being established. In conclusion, given the variety of growth factors involved in the complex cascade of bone repair and the biological interactions between them, it remains a challenge to accomplish the ideal strategy to stimulate reparational bone formation in specific conditions of the medical as in the dental practices.

Prostaglandins control osteoblastic and osteoclastic function under physiological or pathological conditions and are important modulators of the bone healing process. The non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) activity and consequently prostaglandins synthesis. Experimental and clinical evidence has indicated a risk for reparative bone formation related to the use of non-selective (COX-1 and COX-2) and COX-2 selective NSAIDs. Ketorolac is a non-selective NSAID which, at low doses, has a preferential COX-1 inhibitory effect and etoricoxib is a new selective COX-2 inhibitor. Although literature data have suggested that ketorolac can interfere negatively with long bone fracture healing, there seems to be no study associating etoricoxib with reparative bone formation. Paracetamol/acetaminophen, one of the first choices for pain control in clinical dentistry, has been considered a weak anti-inflammatory drug, although supposedly capable of inhibiting COX-2 activity in inflammatory sites. OBJECTIVE: The purpose of the present study was to investigate whether paracetamol, ketorolac and etoricoxib can hinder alveolar bone formation, taking the filling of rat extraction socket with newly formed bone as experimental model. MATERIAL AND METHODS: The degree of new bone formation inside the alveolar socket was estimated two weeks after tooth extraction by a differential point-counting method, using an optical microscopy with a digital camera for image capture and histometry software. Differences between groups were analyzed by ANOVA after confirming a normal distribution of sample data. RESULTS AND CONCLUSIONS: Histometric results confirmed that none of the tested drugs had a detrimental effect in the volume fraction of bone trabeculae formed inside the alveolar socket.

Epidemiological studies have suggested that cola beverage consumption may affect bone metabolism and increase bone fracture risk. Experimental evidence linking cola beverage consumption to deleterious effects on bone is lacking. Herein, we investigated whether cola beverage consumption from weaning to early puberty delays the rate of reparative bone formation inside the socket of an extracted tooth in rats. Twenty male Wistar rats received cola beverage (cola group) or tap water (control group) ad libitum from the age of 23 days until tooth extraction at 42 days and euthanasia 2 and 3 weeks later. The neoformed bone volume inside the alveolar socket was estimated in semi-serial longitudinal sections using a quantitative differential point-counting method. Histological examination suggested a decrease in the osteogenic process within the tooth sockets of rats from both cola groups, which had thinner and sparser new bone trabeculae. Histometric data confirmed that alveolar bone healing was significantly delayed in cola-fed rats at three weeks after tooth extraction (ANOVA, p = 0.0006, followed by Tukey's test, p < 0.01). Although the results of studies in rats cannot be extrapolated directly to human clinical dentistry, the present study provides evidence that cola beverage consumption negatively affect maxillary bone formation.